KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Restructuring Costs (2021 - 2023)

Historic Restructuring Costs for Pacific Biosciences Of California (PACB) over the last 2 years, with Q4 2023 value amounting to $63000.0.

  • Pacific Biosciences Of California's Restructuring Costs changed N/A to $63000.0 in Q4 2023 from the same period last year, while for Dec 2024 it was $9.0 million, marking a year-over-year decrease of 7749.12%. This contributed to the annual value of $9.0 million for FY2023, which is N/A changed from last year.
  • Pacific Biosciences Of California's Restructuring Costs amounted to $63000.0 in Q4 2023.
  • Over the past 5 years, Pacific Biosciences Of California's Restructuring Costs peaked at $30.7 million during Q3 2021, and registered a low of $63000.0 during Q4 2023.